New Therapeutic Horizons in Chronic Kidney Disease: The Role of SGLT2 Inhibitors in Clinical Practice

Overview of attention for article published in Drugs, December 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

twitter: 2 X users

Readers on

mendeley: 36 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Sodium-glucose Cotransporter-2 Inhibitors for Chronic Kidney Disease

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 26 Sep 2022

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.